Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study.
Journal: The oncologist
Published: December 22, 2022
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Journal: The Lancet. Oncology
Published: January 22, 2021
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2020
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2020
Development of a novel tricyclic class of potent and selective FIXa inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: May 21, 2015
Rapid development of two factor IXa inhibitors from hit to lead.
Journal: Bioorganic & medicinal chemistry letters
Published: March 07, 2015
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®.
Journal: Bioorganic & medicinal chemistry letters
Published: November 04, 2013
Showing 1-7 of 7
Last Updated: 09/26/2026